Jonathan Chung to High-Throughput Nucleotide Sequencing
This is a "connection" page, showing publications Jonathan Chung has written about High-Throughput Nucleotide Sequencing.
Connection Strength
0.370
-
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling. Lung Cancer. 2020 10; 148:69-78.
Score: 0.147
-
Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA. J Mol Diagn. 2018 09; 20(5):686-702.
Score: 0.127
-
Pan-Cancer Analysis of CDK12 Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype. Oncologist. 2019 12; 24(12):1526-1533.
Score: 0.034
-
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy. Oncologist. 2019 06; 24(6):791-797.
Score: 0.032
-
Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the GPR98 Locus on 5q14.3. Circ Cardiovasc Genet. 2017 Oct; 10(5).
Score: 0.030